StockNews.com began coverage on shares of Cutera (NASDAQ:CUTR – Get Free Report) in a research report issued on Saturday. The firm set a “sell” rating on the medical device company’s stock.
Cutera Trading Up 2.9 %
Cutera stock opened at $0.33 on Friday. The business’s 50 day simple moving average is $0.44 and its 200 day simple moving average is $0.84. Cutera has a 12 month low of $0.28 and a 12 month high of $4.97. The company has a market cap of $6.62 million, a price-to-earnings ratio of -0.05 and a beta of 1.26.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in CUTR. Ground Swell Capital LLC bought a new stake in Cutera in the 2nd quarter valued at about $37,000. Bank of Montreal Can boosted its position in Cutera by 14.2% during the second quarter. Bank of Montreal Can now owns 282,704 shares of the medical device company’s stock worth $455,000 after purchasing an additional 35,248 shares during the period. Finally, Squarepoint Ops LLC increased its stake in shares of Cutera by 164.5% in the second quarter. Squarepoint Ops LLC now owns 113,964 shares of the medical device company’s stock worth $172,000 after purchasing an additional 70,870 shares in the last quarter. Institutional investors own 90.70% of the company’s stock.
Cutera Company Profile
Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.
Featured Articles
- Five stocks we like better than Cutera
- How to Use Stock Screeners to Find Stocks
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- How to Use High Beta Stocks to Maximize Your Investing Profits
- These 3 Quirky ETFs May Be Strong Plays in 2025
- Want to Profit on the Downtrend? Downtrends, Explained.
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.
